Mark C Jasek

566 total citations
9 papers, 428 citations indexed

About

Mark C Jasek is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark C Jasek has authored 9 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Ophthalmology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark C Jasek's work include Glaucoma and retinal disorders (5 papers), Ocular Surface and Contact Lens (4 papers) and Retinal Diseases and Treatments (3 papers). Mark C Jasek is often cited by papers focused on Glaucoma and retinal disorders (5 papers), Ocular Surface and Contact Lens (4 papers) and Retinal Diseases and Treatments (3 papers). Mark C Jasek collaborates with scholars based in United States, Australia and Mexico. Mark C Jasek's co-authors include Jeanette A. Stewart, William C. Stewart, Robert D. Fechtner, Donald L. Budenz, David G. Godfrey, Nathan M. Radcliffe, Jason K. Darlington, Ahmad A. Aref, Khaled Bahjri and Gabriel Lazcano-Gómez and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, Journal of Cataract & Refractive Surgery and Cornea.

In The Last Decade

Mark C Jasek

9 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark C Jasek United States 7 370 266 229 58 30 9 428
Jean-Marc Guenoun France 6 329 0.9× 252 0.9× 176 0.8× 15 0.3× 13 0.4× 7 380
Steven L. Maskin United States 9 205 0.6× 370 1.4× 152 0.7× 20 0.3× 86 2.9× 18 418
Ronan Conlon Canada 6 247 0.7× 107 0.4× 214 0.9× 21 0.4× 4 0.1× 8 321
Robert T. Ang United States 4 170 0.5× 152 0.6× 221 1.0× 9 0.2× 12 0.4× 5 283
Yasmine M. El Sayed Egypt 12 357 1.0× 61 0.2× 278 1.2× 51 0.9× 5 0.2× 30 400
Alessandro Autelitano Italy 8 342 0.9× 111 0.4× 179 0.8× 53 0.9× 2 0.1× 15 408
Guna Laganovska Latvia 7 376 1.0× 68 0.3× 223 1.0× 18 0.3× 3 0.1× 31 410
Charles S. Ostrov United States 8 321 0.9× 148 0.6× 306 1.3× 6 0.1× 13 0.4× 9 446
Mario G. Fsadni United Kingdom 9 279 0.8× 80 0.3× 139 0.6× 7 0.1× 9 0.3× 25 349
Frances Meier-Gibbons Switzerland 10 205 0.6× 65 0.2× 163 0.7× 24 0.4× 3 0.1× 22 278

Countries citing papers authored by Mark C Jasek

Since Specialization
Citations

This map shows the geographic impact of Mark C Jasek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C Jasek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C Jasek more than expected).

Fields of papers citing papers by Mark C Jasek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C Jasek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C Jasek. The network helps show where Mark C Jasek may publish in the future.

Co-authorship network of co-authors of Mark C Jasek

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C Jasek. A scholar is included among the top collaborators of Mark C Jasek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C Jasek. Mark C Jasek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Malhotra, Ranjan, et al.. (2019). <p>Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects</p>. Clinical ophthalmology. Volume 13. 403–413. 12 indexed citations
3.
Sheppard, John D., Paul Cockrum, Angela Justice, & Mark C Jasek. (2018). In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits. Ophthalmology and Therapy. 7(1). 157–165. 16 indexed citations
4.
Seibold, Leonard K., Nathan M. Radcliffe, Syril Dorairaj, et al.. (2017). Goniotomy with a single-use dual blade: Short-term results. Journal of Cataract & Refractive Surgery. 43(9). 1197–1201. 96 indexed citations
5.
Jasek, Mark C, et al.. (2016). A Novel Dual Blade Device for Goniotomy: Initial Clinical Experience. 57(12). 6522–6522. 2 indexed citations
6.
Fechtner, Robert D., David G. Godfrey, Donald L. Budenz, et al.. (2010). Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications. Cornea. 29(6). 618–621. 269 indexed citations
7.
Goldberg, Ivan, Jonathan G. Crowston, Mark C Jasek, Jeanette A. Stewart, & William C. Stewart. (2010). Intraocular Pressure-lowering Efficacy of Brinzolamide When Added to Travoprost/Timolol Fixed Combination as Adjunctive Therapy. Journal of Glaucoma. 21(1). 55–59. 12 indexed citations
8.
Godfrey, David G., Robert D. Fechtner, Donald L. Budenz, William C. Stewart, & Mark C Jasek. (2008). Increased Prevalence of Ocular Surface Disease Symptoms in Glaucoma Patients Using IOP-Lowering Medications. Investigative Ophthalmology & Visual Science. 49(13). 5335–5335. 1 indexed citations
9.
Jasek, Mark C, David C. Dahlin, David J. Kay, et al.. (2007). Pharmacokinetics of CIPRODEX® otic in pediatric and adolescent patients. International Journal of Pediatric Otorhinolaryngology. 72(1). 97–102. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026